| 摘要 |
Disclosed is a composition comprising as active ingredients: (a) extract of rice fermented with Monascus purpureus (such as comprising lovastatin / Monacolin K); (b) at least one omega-3 fatty acid (preferably comprising DHA and/or EPA); (c) L-carnitine or a salt thereof (e.g. L-carnitine tartrate); and one or more of the following active ingredients (d) to (g): (d) at least one policosanol or a natural extract containing policosanols (such as selected from the group consisting of triacontanol, hexacosanol, hexacontanol, ecocontanol, tetracosanol, dotriacontanol, and tetracontanol); (e) resveratrol or a natural extract containing resveratrol; (f) Coenzyme Q10 (ubiquinone); and (g) at least one vitamin, wherein the composition is for preventing or treating an altered lipid metabolism and complications thereof, in which said complications are selected from the group consisting of cardiovascular, atherosclerotic and/ or thromboembolic diseases. |
